Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02270060
Other study ID # 08-14-11
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 2014
Est. completion date May 2016

Study information

Verified date August 2019
Source University Hospitals Cleveland Medical Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this research study is to:

1. Investigate the effects of a single 20-minute music therapy intervention with a music therapist on the pain intensity, pain relief, and mood of adult patients with sickle cell disease as compared to:

1. Adult patients with SCD who listen to their preferred music for 20 minutes without the presence of a music therapist (music listening group)

2. Adult patients with SCD who receive standard care alone (control group)

2. Determine the feasibility (delivery, acceptability, and usefulness) of the music therapy intervention for pain management


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date May 2016
Est. primary completion date May 2016
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Subjects who have a diagnosis of sickle cell disease (HbSS, HbSC, HbSbeta+thal, or HbSbeta0thal)

- 18 years or older

- Able to speak and understand English

Exclusion Criteria:

- Patients who have significant hearing impairments and/or significant visual impairments that have not been corrected

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Music Therapy
Patient receives a single 20-minute music therapy session with a music therapist. Patient will interact with specially composed music tailored to the patient's preferences using an iPad.
Music Listening
Patient listens to his/her preferred music on an iPod touch for 20 minutes without the presence of a music therapist.

Locations

Country Name City State
United States University Hospitals Seidman Cancer Center Cleveland Ohio

Sponsors (2)

Lead Sponsor Collaborator
University Hospitals Cleveland Medical Center Kulas Foundation

Country where clinical trial is conducted

United States, 

References & Publications (1)

Guétin S, Giniès P, Siou DK, Picot MC, Pommié C, Guldner E, Gosp AM, Ostyn K, Coudeyre E, Touchon J. The effects of music intervention in the management of chronic pain: a single-blind, randomized, controlled trial. Clin J Pain. 2012 May;28(4):329-37. doi: 10.1097/AJP.0b013e31822be973. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change (Post - Pre) From Baseline in Visual Analog Scale of Pain Intensity (VASPI) of Memorial Pain Assessment Card Visual analog scale of pain intensity. The minimum score is 0. The maximum score is 10. Higher scores represent worse pain intensity. Baseline and at end of 20-minute intervention, up to 120 minutes following randomization
Secondary Change (Post - Pre) From Baseline in Visual Analog Scale of Pain Relief (VASPR) of Memorial Pain Assessment Card Visual analog scale of Pain Relief. The minimum score is 0. The maximum score is 10. Higher scores represent greater pain relief. Baseline and at end of 20-minute intervention, up to 120 minutes following randomization
Secondary Change (Post- Pre) From Baseline in Visual Analog Scale of Mood (VASMOOD) of Memorial Pain Assessment Card Visual analog scale of mood. The minimum score is 0. The maximum score is 10. Higher scores represent better mood. Baseline and at end of 20-minute intervention, up to 120 minutes following randomization
Secondary Change (Post - Pre) From Baseline in Tursky Scale of Memorial Pain Assessment Card Pain adjectives scale. The minimum score is 1. The maximum score is 7. Higher scores represent worse pain. Baseline and at end of 20-minute intervention, up to 120 minutes following randomization
Secondary Length of Stay in Minutes Length of stay (in minutes) in acute care clinic From time of admission into acute care clinic to time of discharge, up to 8 hours.
Secondary Amount of Hydromorphone Amount of Hydromorphone received in acute care clinic following intervention From time of admission into acute care clinic to time of discharge, up to 8 hours.
Secondary Change (Post - Pre) From Baseline in Numeric Pain Rating (NPR) Numeric pain rating between 0-10 before and after admission to acute care clinic. The minimum score is 0. The maximum score is 10. Higher scores represent worse pain. From time of admission into acute care clinic to time of discharge, up to 8 hours.
See also
  Status Clinical Trial Phase
Completed NCT02227472 - Working Memory and School Readiness in Preschool-Aged Children With Sickle Cell Disease
Recruiting NCT06301893 - Uganda Sickle Surveillance Study (US-3)
Recruiting NCT04398628 - ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Completed NCT02522104 - Evaluation of the Impact of Renal Function on the Pharmacokinetics of SIKLOS ® (DARH) Phase 4
Recruiting NCT04688411 - An mHealth Strategy to Improve Medication Adherence in Adolescents With Sickle Cell Disease N/A
Terminated NCT03615924 - Effect of Ticagrelor vs. Placebo in the Reduction of Vaso-occlusive Crises in Pediatric Patients With Sickle Cell Disease Phase 3
Recruiting NCT03937817 - Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants
Completed NCT04134299 - To Assess Safety, Tolerability and Physiological Effects on Structure and Function of AXA4010 in Subjects With Sickle Cell Disease N/A
Completed NCT04917783 - Health Literacy - Neurocognitive Screening in Pediatric SCD N/A
Completed NCT02580565 - Prevalence of Problematic Use of Equimolar Mixture of Oxygen and Nitrous Oxide and Analgesics in the Sickle-cell Disease
Recruiting NCT04754711 - Interest of Nutritional Care of Children With Sickle Cell Disease on Bone Mineral Density and Body Composition N/A
Completed NCT04388241 - Preliminary Feasibility and Efficacy of Behavioral Intervention to Reduce Pain-Related Disability in Pediatric SCD N/A
Recruiting NCT05431088 - A Phase 2/3 Study in Adult and Pediatric Participants With SCD Phase 2/Phase 3
Completed NCT01158794 - Genes Influencing Iron Overload State
Recruiting NCT03027258 - Point-of-Delivery Prenatal Test Results Through mHealth to Improve Birth Outcome N/A
Withdrawn NCT02960503 - Macrolide Therapy to Improve Forced Expiratory Volume in 1 Second in Adults With Sickle Cell Disease Phase 1/Phase 2
Not yet recruiting NCT02525107 - Prevention of Vaso-occlusive Painful Crisis by Using Omega-3 Fatty Acid Supplements Phase 3
Completed NCT02565082 - Evaluation of the Hemostatic Potential in Sickle Cell Disease Patients N/A
Withdrawn NCT02630394 - A Pilot Study of Azithromycin Prophylaxis for Acute Chest Syndrome in Sickle Cell Disease Phase 1
Completed NCT02567695 - A Single-Dose Relative Bioavailability Study Of GBT440 300 mg Capsules in Healthy Subjects Phase 1